Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoregulin pseudogene 1 (MREGP1) is classified as a pseudogene, meaning it is a genomic sequence resembling the functional melanoregulin (MREG) gene but is generally considered nonfunctional and does not encode a protein[1][4]. There is currently no evidence supporting a biological or therapeutic role for MREGP1. Most available scientific studies, including those describing the molecular structure, organelle transport, or disease implications, refer to the related functional gene melanoregulin (MREG) and not to MREGP1 or other pseudogenes[2][3]. If more information about MREGP1 becomes available, molecular classification and disease role data should be updated accordingly. Clarification: - The identifier "MREGP1" is correct for the locus, but it is not a therapeutic target and is only a pseudogene—entries referencing molecular function, drug interactions, or disease association concern the protein-coding gene MREG, not MREGP1[1][4]. - If you intended to inquire about the functional protein "melanoregulin," a distinct entry referring to MREG (the parent protein-coding gene) should be created. Melanoregulin is a vesicular transport protein and is involved in organelle biogenesis and specific pigment cell disorders[2][3]. Summary of findings: - MREGP1 is a pseudogene and not a therapeutic target. - No molecular function, disease role, or drug interactions are known for MREGP1. - Most structured scientific data relate to melanoregulin (MREG), not MREGP1. If you require structured data for the parent gene "melanoregulin (MREG)" as a protein-coding target, that information should be gathered separately.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoregulin pseudogene 1 (MREGP1).